Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors

Yang, V; Kragstrup, TW; McMaster, C; Reid, P; Singh, N; Haysen, SR; Robinson, PC; Liew, DFL

Liew, DFL (通讯作者),Austin Hlth, Heidelberg Repatriat Hosp, Dept Rheumatol, Level 1,North Wing,POB 5444,300 Waterdale Rd, Heidelberg West, Vic 3081, Australia.;Liew, DFL (通讯作者),Austin Hlth, Dept Clin Pharmacol & Therapeut, Melbourne, Vic, Australia.;Liew, DFL (通讯作者),Univ Melbourne, Dept Med, Melbourne, Vic, Australia.

DRUG SAFETY, 2023; 46 (11): 1049

Abstract

Janus kinase inhibitors (JAKi) have enormous appeal as immune-modulating therapies across many chronic inflammatory diseases, but recently this promis......

Full Text Link